Arrowstreet Capital Limited Partnership Purchases New Position in...
Arrowstreet Capital Limited Partnership purchased a new position in shares of Valeant Pharmaceuticals International, Inc. during the fourth quarter, Holdings Channel reports. The institutional investor purchased 585,126 shares of the specialty pharmaceutical company's stock, valued at approximately $8,495,000.
from Biotech News
0 Comments